Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.23.2
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Product revenue, net $ 16,961 $ 18,235 $ 29,126 $ 39,031
Collaboration revenue 183 577 364 1,154
Other revenue 211 56 259 2,556
Net revenue 17,386 18,886 29,815 42,811
Related Party [Member]        
Revenue - related party 31 18 66 70
Qbrexza        
Product revenue, net 8,079 6,111 12,173 13,487
Other revenue     2,500  
Accutane        
Product revenue, net 5,579 5,200 10,227 10,107
Amzeeq        
Product revenue, net 1,374 1,265 2,568 4,731
Targadox        
Product revenue, net 664 2,756 1,457 5,390
Ximino        
Product revenue, net 155 1,035 766 2,002
Zilxi        
Product revenue, net 572 555 886 1,297
Exelderm        
Product revenue, net $ 538 $ 1,313 $ 1,049 $ 2,017